Celltech Details Phase III Trial Plans For CDP870 In Crohn's Jan. 7, 2004 By Aaron Lorenzo No Comments A Phase III program in Crohn's disease is under way to evaluate a compound being developed by Celltech Group plc. (BioWorld International)Read More
Millennium Halts Phase II Velcade Combination Trial In Colon Cancer Jan. 7, 2004 By Aaron Lorenzo No Comments
Celltech Details Phase III Trial Plans For CDP870 In Crohn's Jan. 7, 2004 By Aaron Lorenzo No Comments
Millennium Halts Phase II Velcade Combination Trial In Colon Cancer Jan. 7, 2004 By Aaron Lorenzo No Comments
Celltech Details Phase III Trial Plans For CDP870 In Crohn's Jan. 7, 2004 By Aaron Lorenzo No Comments A Phase III program in Crohn's disease is under way to evaluate a compound being developed by Celltech Group plc. (BioWorld International)Read More
Dynogen Teams Up With J&J Unit For Overactive Bladder Treatment Jan. 6, 2004 By Aaron Lorenzo No Comments
Dynogen Teams Up With J&J Unit For Overactive Bladder Treatment Jan. 6, 2004 By Aaron Lorenzo No Comments
Cell Therapy Deal With Amgen Worth At Least $20M To ViaCell Jan. 5, 2004 By Aaron Lorenzo No Comments
Cell Therapy Deal With Amgen Worth At Least $20M To ViaCell Jan. 5, 2004 By Aaron Lorenzo No Comments
